That is the topic of a JAMA Health Forum article by my USC colleagues Dana Goldman and Erin Trish. In it, the note that the Congressional Budget Office (CBO) does good work, but the scope of their analysis is limited. CBO only estimates the impact on policies on government budgets; CBO’s remit does not evaluate…
Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sector as it deepens its healthcare push ahead of a widely anticipated IPO. The post Anthropic Launches Claude Science to Court Pharma Ahead of…
Servier completed its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular business is expected to close later this year. At the BIO International Convention, Servier’s top business development executive explained the rationale for these deals and how they fit the company’s overall strategy. The post Servier Executive: ‘We Are Not Looking…
Federal agencies managing large EHR systems have made progress but still face management gaps
Zelis has introduced an AI solution to help health insurers streamline the No Surprises Act’s Independent Dispute Resolution process. The post Zelis Unveils Solution to Tackle Payer IDR Challenges appeared first on MedCity News.
This brief provides an overview of the relationship between racial discrimination and health and highlights research examining mechanisms underlying health outcomes linked to experiences of racial discrimination, including biological changes, chronic stress, mental health, substance use, pregnancy-related outcomes, and sleep.
In this month’s pivot podcast, I speak to the chief medical officer of San Francisco-based Vynca, an innovative company in the world of palliative care that is providing serious disease management at home. The post MedCity Pivot Podcast: The Evolution of At-Home Care appeared first on MedCity News.
U.S. federal health leaders are advancing a coordinated strategy to embed AI into healthcare, emphasizing infrastructure, governance and practical deployment to improve clinical outcomes and reduce costs.
This requires more than deploying the right technology. It demands a reevaluation of how these systems fit into the healthcare environment and how to bring patients and staff along. The post Hospitals Have Always Had Eyes — AI is Giving Them a Brain appeared first on MedCity News.
We should ask a more nuanced question than “does AI work in drug discovery.” Rather, we should ask which approaches are about to be proven, and which are about to be exposed, because the field is several bets, and they are not equally sound. The post The AI Drug Discovery Race Is Heating Up, Not…